Offer - Urjas Oil for just ₹ 1
Brimotim is a prescription drug, available for use as Drops. Brimotim also has some secondary and off-label uses. These are listed below.
The optimal dosage of Brimotim is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Brimotim include Eye Burning, Eye irritation, Stinging in the Eyes. Apart from the aforementioned side effects, Brimotim can also lead to other problems, which have been listed below. These side effects of Brimotim are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Brimotim's effect during pregnancy is Mild and Unknown while nursing. Further, the section on Brimotim related warnings talks about Brimotim's effects on the liver, heart and kidney.
Brimotim is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) are examples of such conditions. The section on Brimotim contraindications lists all such conditions.
Additionally, Brimotim may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Brimotim, it is important to know that it is safe while driving, and is habit-forming.
Brimotim is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Is the use of Brimotim safe for pregnant women?
Brimotim has little to no side effects in pregnant women.
Is the use of Brimotim safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Brimotim for breastfeeding women are not known.
What is the effect of Brimotim on the Kidneys?
Kidney can be affected by Brimotim. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Brimotim on the Liver?
Brimotim may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Brimotim on the Heart?
The heart can be affected by Brimotim. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Brimotim should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Brimotim unless your doctor advises you to do so -
Is this Brimotim habit forming or addictive?
No, you will not get addicted to Brimotim.
Interaction between Food and Brimotim
Taking Brimotim with food does not harm your health.
Interaction between Alcohol and Brimotim
No research has been done on this till date. Therefore, it is not known what the effect of taking Brimotim with alcohol will be.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)
